Activin and TGFβ regulate expression of the microRNA-181 family to promote cell migration and invasion in breast cancer cells

Cellular Signalling

Volumn 25, Issue 7, 2013, Pages 1556-1566

  Neel, Jean Charles ^a   Lebrun, Jean Jacques ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Activin; Breast cancer; Migration; MiR 181; TGF

Indexed keywords

ACTIVIN; MICRORNA; MICRORNA 181; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; MIRN181 MICRORNA, HUMAN; SMAD2 PROTEIN; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN; SMAD3 PROTEIN, HUMAN;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; BREAST TUMOR; CELL MOTION; CELL PROLIFERATION; FEMALE; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION;

ACTIVINS; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84877037101     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2013.03.013     Document Type: Article

References (86)

1. Massague J. Cell 2008, 134:215-230.
2. Humbert L., Neel J.C., Lebrun J.J. Trends in Cell & Molecular Biology 2010, 5:69-107.
3. Korah J., Falah N., Lacerte A., Lebrun J.J. Cell Death and Diseases 2012, 3:e407.
4. Valderrama-Carvajal H., Cocolakis E., Lacerte A., Lee E.H., Krystal G., et al. Nature Cell Biology 2002, 4:963-969.
5. Humbert L., Lebrun J.J. Cellular Signalling 2012, 25:490-500.
6. Massague J. Annual Review of Biochemistry 1998, 67:753-791.
7. Roberts A.B., Wakefield L.M. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:8621-8623.
8. Dumont N., Arteaga C.L. Cancer Cell 2003, 3:531-536.
9. Lebrun J.J. ISRN Molecular Biology 2012, 2012:28.
10. Dai M., Al-Odaini A.A., Arakelian A., Rabbani S.A., Ali S., et al. Breast Cancer Research 2012, 14:R127.
11. Neel J.C., Humbert L., Lebrun J.J. Medecine Sciences Amerique 2012, 1:87-113.
12. Wrana J.L., Attisano L., Wieser R., Ventura F., Massague J. Nature 1994, 370:341-347.
13. Vale W., Rivier J., Vaughan J., McClintock R., Corrigan A., et al. Nature 1986, 321:776-779.
14. Ling N., Ying S.Y., Ueno N., Shimasaki S., Esch F., et al. Nature 1986, 321:779-782.
15. Vale W., Rivier C., Hsueh A., Campen C., Meunier H., et al. Recent Progress in Hormone Research 1988, 44:1-34.
16. Lebrun J.J. Advances in Experimental Medicine and Biology 2009, 668:69-78.
17. Lacerte A., Lee E.H., Reynaud R., Canaff L., De Guise C., et al. Molecular Endocrinology 2004, 18:1558-1569.
18. Cocolakis E., Lemay S., Ali S., Lebrun J.J. Journal of Biological Chemistry 2001, 276:18430-18436.
19. Lebrun J.J., Vale W.W. Molecular and Cellular Biology 1997, 17:1682-1691.
20. Lebrun J.J., Chen Y., Vale W.W. Serono Symposia Publication. Inhibin, Activin and Follistatin, Regulatory Functions in System and Cell Biology 1997, 1-20. Springer-Verlag New York, Inc.
21. Ho J., de Guise C., Kim C., Lemay S., Wang X.F., et al. Cellular Signalling 2004, 16:693-701.
22. Attisano L., Carcamo J., Ventura F., Weis F.M., Massague J., et al. Cell 1993, 75:671-680.
23. Lebrun J.J., Takabe K., Chen Y., Vale W. Molecular Endocrinology 1999, 13:15-23.
24. Derynck R., Zhang Y.E. Nature 2003, 425:577-584.
25. de Guise C., Lacerte A., Rafiei S., Reynaud R., Roy M., et al. Endocrinology 2006, 147:4351-4362.
26. Jeruss J.S., Santiago J.Y., Woodruff T.K. Molecular and Cellular Endocrinology 2003, 203:185-196.
27. Robinson G.W., Hennighausen L. Development 1997, 124:2701-2708.
28. Liu Q.Y., Niranjan B., Gomes P., Gomm J.J., Davies D., et al. Cancer Research 1996, 56:1155-1163.
29. Chen Y.G., Wang Q., Lin S.L., Chang C.D., Chuang J., et al. Experimental Biology and Medicine (Maywood, N.J.) 2006, 231:534-544.
30. Katik I., Mackenzie-Kludas C., Nicholls C., Jiang F.X., Zhou S., et al. Biochemical and Biophysical Research Communications 2009, 389:668-672.
31. Lacerte A., Korah J., Roy M., Yang X.J., Lemay S., et al. Cellular Signalling 2008, 20:50-59.
32. Leto G., Incorvaia L., Badalamenti G., Tumminello F.M., Gebbia N., et al. Clinical & Experimental Metastasis 2006, 23:117-122.
33. Chantry A.D., Heath D., Mulivor A.W., Pearsall S., Baud'huin M., et al. Journal of Bone and Mineral Research 2010, 25:2633-2646.
34. Lee R.C., Feinbaum R.L., Ambros V. Cell 1993, 75:843-854.
35. Ahmed F.E. Expert Review of Molecular Diagnostics 2007, 7:569-603.
36. Boominathan L. PLoS One 2010, 5:e10615.
37. Burrow A.A., Williams L.E., Pierce L.C., Wang Y.H. BMC Genomics 2009, 10:59.
38. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., et al. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:2999-3004.
39. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., et al. Nature Cell Biology 2008, 10:593-601.
40. Tsai Z.Y., Singh S., Yu S.L., Kao L.P., Chen B.Z., et al. Journal of Cellular Biochemistry 2010, 109:93-102.
41. Valastyan S., Benaich N., Chang A., Reinhardt F., Weinberg R.A. Genes & Development 2009, 23:2592-2597.
42. Gregory P.A., Bracken C.P., Smith E., Bert A.G., Wright J.A., et al. Molecular Biology of the Cell 2011, 22:1686-1698.
43. Fils-Aimé N., Dai M., Guo J., Kahramangil B., Neel J., et al. Journal of Biological Chemistry 2012.
44. Kong D., Li Y., Wang Z., Banerjee S., Ahmad A., et al. Stem Cells 2009, 27:1712-1721.
45. Ma S., Tang K.H., Chan Y.P., Lee T.K., Kwan P.S., et al. Cell Stem Cell 2010, 7:694-707.
46. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., et al. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:2257-2261.
47. Shi L., Cheng Z., Zhang J., Li R., Zhao P., et al. Brain Research 2008, 1236:185-193.
48. Wang B., Hsu S.H., Majumder S., Kutay H., Huang W., et al. Oncogene 2010, 29:1787-1797.
49. Wang Y., Yu Y., Tsuyada A., Ren X., Wu X., et al. Oncogene 2011, 30:1470-1480.
50. Taylor M.A., Sossey-Alaoui K., Thompson C.L., Danielpour D., Schiemann W.P. The Journal of Clinical Investigation 2012.
51. Li Z., Huang H., Li Y., Jiang X., Chen P., et al. Blood 2012, 119:2314-2324.
52. Chen G., Zhu W., Shi D., Lv L., Zhang C., et al. Oncology Reports 2010, 23:997-1003.
53. Minn A.J., Kang Y., Serganova I., Gupta G.P., Giri D.D., et al. The Journal of Clinical Investigation 2005, 115:44-55.
54. Leto G. Journal of Cellular Physiology 2010, 225:302-309.
55. Inman G.J., Nicolas F.J., Callahan J.F., Harling J.D., Gaster L.M., et al. Molecular Pharmacology 2002, 62:65-74.
56. Wu H., Lima W.F., Zhang H., Fan A., Sun H., et al. Journal of Biological Chemistry 2004, 279:17181-17189.
57. Cheng A.M., Byrom M.W., Shelton J., Ford L.P. Nucleic Acids Research 2005, 33:1290-1297.
58. Benson J.R. The Lancet Oncology 2004, 5:229-239.
59. Ho J., Cocolakis E., Dumas V.M., Posner B.I., Laporte S.A., et al. EMBO Journal 2005, 24:3247-3258.
60. Hu M.G., Hu G.F., Kim Y., Tsuji T., McBride J., et al. Cancer Research 2004, 64:490-499.
61. Dai M, Al-Odaini A, Arakelian A, Rabbani S, Ali S, et al. in press. p21 and p/CAF regulate TGFß-induced cell migration and invasion in breast cancer. Breast Cancer Research.
62. Kang H.Y., Shyr C.R. Vitamins and Hormones 2011, 85:129-148.
63. Kang H.Y., Huang H.Y., Hsieh C.Y., Li C.F., Shyr C.R., et al. Journal of Bone and Mineral Research 2009, 24:1180-1193.
64. Salogni L., Musso T., Bosisio D., Mirolo M., Jala V.R., et al. Blood 2009, 113:5848-5856.
65. Li Q.J., Zhou L., Yang F., Wang G.X., Zheng H., et al. Tumour Biology 2012, 33:1455-1465.
66. Zhu J., Feng Y., Ke Z., Yang Z., Zhou J., et al. American Journal of Pathology 2012, 180:2440-2451.
67. Funaba M., Ikeda T., Ogawa K., Murakami M., Abe M. Journal of Leukocyte Biology 2003, 73:793-801.
68. Jung B.H., Beck S.E., Cabral J., Chau E., Cabrera B.L., et al. Gastroenterology 2007, 132:633-644.
69. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:3983-3988.
70. Meyer M.J., Fleming J.M., Ali M.A., Pesesky M.W., Ginsburg E., et al. Breast Cancer Research 2009, 11:R82.
71. Xia H., Qi Y., Ng S.S., Chen X., Li D., et al. Brain Research 2009, 1269:158-165.
72. Zhang J., Luo N., Luo Y., Peng Z., Zhang T., et al. International Journal of Oncology 2012, 40:747-756.
73. Cheng C.W., Wang H.W., Chang C.W., Chu H.W., Chen C.Y., et al. Breast Cancer Research and Treatment 2012, 134:1081-1093.
74. Bauer J., Sporn J.C., Cabral J., Gomez J., Jung B. PLoS One 2012, 7:e39381.
75. Ottley E., Gold E. Cytokine & Growth Factor Reviews 2012, 23:119-125.
76. Chen R.H., Su Y.H., Chuang R.L., Chang T.Y. Oncogene 1998, 17:1959-1968.
77. Peron P., Rahmani M., Zagar Y., Durand-Schneider A.M., Lardeux B., et al. Journal of Biological Chemistry 2001, 276:10524-10531.
78. Muraoka R.S., Koh Y., Roebuck L.R., Sanders M.E., Brantley-Sieders D., et al. Molecular and Cellular Biology 2003, 23:8691-8703.
79. Siegel P.M., Shu W., Cardiff R.D., Muller W.J., Massague J. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:8430-8435.
80. Chytil A., Magnuson M.A., Wright C.V., Moses H.L. Genesis 2002, 32:73-75.
81. Munoz N.M., Upton M., Rojas A., Washington M.K., Lin L., et al. Cancer Research 2006, 66:9837-9844.
82. Ijichi H., Chytil A., Gorska A.E., Aakre M.E., Fujitani Y., et al. Genes & Development 2006, 20:3147-3160.
83. Forrester E., Chytil A., Bierie B., Aakre M., Gorska A.E., et al. Cancer Research 2005, 65:2296-2302.
84. Yang L., DeBusk L.M., Fukuda K., Fingleton B., Green-Jarvis B., et al. Cancer Cell 2004, 6:409-421.
85. Yang L., Huang J., Ren X., Gorska A.E., Chytil A., et al. Cancer Cell 2008, 13:23-35.
86. Drakaki A., Hatziapostolou M., Iliopoulos D. Current Pharmaceutical Design 2012.